Advertisement

Glaucoma: Comorbidity with Dry Eye Disease

  • Giedre Pakuliene
Chapter

Abstract

Prescribing the right antiglaucomatous medication can be an even more challenging task, if the patient has a preexisting ocular surface disease. Identification of these patients is very important prior to medical glaucoma treatment.

References

  1. 1.
    Erb C, Gast U, Schremmer D. German Register for Glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefes Arch Clin Exp Ophthalmol. 2008;246(11):1593–601.  https://doi.org/10.1007/s00417-008-0881-9.CrossRefPubMedGoogle Scholar
  2. 2.
    Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea. 2010;29(6):618–21.  https://doi.org/10.1097/ICO.0b013e3181c325b2.CrossRefPubMedGoogle Scholar
  3. 3.
    Rossi GCM, Pasinetti GM, Scudeller L, Bianchi PE. Ocular surface disease and glaucoma: how to evaluate impact on quality of life. J Ocul Pharmacol Ther. 2013;29(4):390–4.  https://doi.org/10.1089/jop.2011.0159.CrossRefPubMedGoogle Scholar
  4. 4.
    Vagge A, Bonino M, Rolando M, Macrì A, Traverso CE, Iester M. The utility of an artificial substitute to improve corneal sensitivity in glaucomatous patients on chronic therapy with prostaglandin analogs. J Ocul Pharmacol Ther. 2015;31(5):286–90.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Giedre Pakuliene
    • 1
  1. 1.Lithuanian University of Health ScienceKaunasLithuania

Personalised recommendations